Insulin resistance and exendin-4 treatment for multiple system atrophy-Reference-Cited by-同舟云学术

Insulin resistance and exendin-4 treatment for multiple system atrophy

Published:2017-03-14 Issue:5 Volume:140 Page:1420-1436
ISSN:0006-8950
Container-title:Brain
language:en
Short-container-title:

Author:

Bassil Fares¹²,Canron Marie-Hélène¹²,Vital Anne¹²³,Bezard Erwan¹²,Li Yazhou⁴,Greig Nigel H⁴,Gulyani Seema⁵,Kapogiannis Dimitrios⁵,Fernagut Pierre-Olivier¹²,Meissner Wassilios G¹²⁶⁷

Affiliation:

1. Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France

2. CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France

3. Service de Pathologie, CHU de Bordeaux, 33000 Bordeaux, France

4. Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, Baltimore, MD 21224, USA

5. Laboratory of Neurosciences, National Institute on Aging, Baltimore, MD 21224, USA

6. Centre de Référence Maladie Rare AMS, Hôpital Pellegrin, CHU de Bordeaux, F-33076 Bordeaux, France

7. Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000 Bordeaux, France

Funder

National Institutes of Health

National Institute on Aging

MSA Coalition

LABEX BRAIN

Publisher

Oxford University Press (OUP)

Subject

Neurology (clinical)

Link

http://academic.oup.com/brain/article-pdf/140/5/1420/24175049/awx044.pdf

Reference59 articles.

1. Exenatide and the treatment of patients with Parkinson’s disease;Aviles-Olmos;J Clin Invest,2013

2. Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson’s disease;Aviles-Olmos;J Parkinsons Dis,2014

3. Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?;Bassil;Prog Neurobiol,2014

4. Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy;Bassil;Proc Natl Acad Sci USA,2016

5. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease- associated Abeta oligomers;Bomfim;J Clin Invest,2012

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-diabetic drug use and reduced risk of Parkinson's disease: A community-based cohort study;Parkinsonism & Related Disorders;2024-11

2. Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review;Neurology and Therapy;2024-05-14

3. The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology;International Journal of Molecular Sciences;2024-04-15

4. Sitagliptin elevates plasma and CSF incretin levels following oral administration to nonhuman primates: relevance for neurodegenerative disorders;GeroScience;2024-03-27

5. Multiple system atrophy: an update and emerging directions of biomarkers and clinical trials;Journal of Neurology;2024-03-14